A Sustainable Approach to Increasing Cancer Screening (CATCH)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study, A Coordinated Approach to Cancer and Health (CATCH), is designed to compare the efficacy of two intervention arms (described below) intended to increase breast, cervical, and colon cancer screening rates among patients served by community health centers. A central focus of CATCH is to evaluate sustainable strategies for maximizing cancer screening rates among populations facing significant cancer disparities.
CATCH is being conducted in partnership with the Greater Lawrence Family Health Center (GLFHC, Lawrence, MA). Focusing on the use of an Interactive Voice Response (IVR) telephone technology system, the study is examining the extent to which the IVR, when developed in a culturally sensitive and appropriate manner, can improve breast, cervical and colon cancer screening rates compared to a control group. Furthermore, we will determine if pairing IVR with telephone calls from a prevention care coordinator (PCC) will result in higher screening rates (when compared to the IVR only group). We will determine the cost-effectiveness of IVR alone vs. IVR + PCC.
| Condition | Intervention |
|---|---|
|
Colorectal Cancer Breast Cancer Cervical Cancer |
Behavioral: IVR only Behavioral: IVR+PCC |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Screening |
| Official Title: | A Sustainable Approach to Increasing Cancer Screening |
- Change in population level cancer screening level at GLFHC clinics. [ Time Frame: year 3 of the study ] [ Designated as safety issue: No ]The primary outcome of interest is improvement of population-level screening for 3 cancers (breast, cervical, and colorectal).
- Assessment of study arm effectiveness. [ Time Frame: year 3 of the study ] [ Designated as safety issue: No ]In the study we have 3 arms: 1) (UC), 2)Interactive Voice Response system (IVR)only, and 3) IVR + prevention care coordinator calls (PCC)with the rate of interaction with IVR vs. IVR + MA. We will compare all three arms to see which one held the most improvement in terms of screening rates.
| Estimated Enrollment: | 13675 |
| Study Start Date: | September 2008 |
| Estimated Study Completion Date: | January 2013 |
| Primary Completion Date: | March 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| No Intervention: control | |
| Experimental: IVR only |
Behavioral: IVR only
consistent, but spaced out calls generated by an interactive voice response system
|
| Experimental: IVR+PCC |
Behavioral: IVR+PCC
Interactive voice response calls followed up by prevention care coordinator calls for those who do not respond to IVR
|
Eligibility| Ages Eligible for Study: | 21 Years to 86 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion criteria
- All age and gender eligible patients, using GLFHC's guidelines, in need of: breast, cervical or colorectal cancer screenings.
Exclusion criteria
- All GLFHC patients who do are not age or gender eligible for a breast, cervical or colorectal cancer screening.
Contacts and Locations| United States, Massachusetts | |
| Greater Lawrence Family Health Center (GLFHC) | |
| Lawrence, Massachusetts, United States, 01841 | |
| Principal Investigator: | Karen M Emmons, PhD | Dana-Farber Cancer Institution |
More Information
No publications provided
| Responsible Party: | Karen Emmons, Principal Investigator, Harvard School of Public Health |
| ClinicalTrials.gov Identifier: | NCT01395459 History of Changes |
| Other Study ID Numbers: | 15622, R01CA126596 |
| Study First Received: | July 9, 2011 |
| Last Updated: | September 12, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by Harvard School of Public Health:
|
screening cancer prevention IVR |
Additional relevant MeSH terms:
|
Breast Neoplasms Uterine Cervical Neoplasms Colorectal Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Uterine Cervical Diseases |
Uterine Diseases Genital Diseases, Female Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on May 22, 2013